Barrington James · 2 months ago
Freelance Market Access Consultant (Japanese-speaking / English translation)
Barrington James is a leading global pharmaceutical company seeking a Japanese-speaking Market Access Consultant to support evidence-based market access strategies and reimbursement submissions. The role involves translating complex documents from Japanese to English and collaborating with various teams to support global and regional access strategies.
Health CareRecruiting
Responsibilities
Provide expertise on Japanese market access, pricing, and reimbursement processes
Translate scientific, clinical, and market access documents from Japanese to English, ensuring accuracy and clarity for international stakeholders
Collaborate with Market Access, HEOR, and Medical Affairs teams to support global and regional access strategies
Support preparation of HTA submissions, payer dossiers, and stakeholder communications in Japan
Provide insights on local payer landscape, reimbursement trends, and pricing negotiations
Engage with internal teams to ensure consistent messaging across Japanese and global markets
Qualification
Required
Advanced degree in Life Sciences, Health Economics, Market Access, or related field
5+ years of experience in pharmaceutical market access, ideally with exposure to Japanese HTA (e.g., MHLW, NHI) and payer processes
Fluent in Japanese and English, with professional translation experience
Strong understanding of healthcare systems, pricing, and reimbursement in Japan
Excellent communication, project management, and cross-cultural collaboration skills
Benefits
Flexible freelance engagement with exposure to high-impact global projects
Work closely with senior leadership and cross-functional teams across regions
Competitive daily or hourly rate based on experience
Company
Barrington James
Barrington James has a true global reach, with its international HQ in London-Gatwick, continental hubs in Singapore.
Funding
Current Stage
Growth StageTotal Funding
unknownKey Investors
Orangewood Partners
2022-10-05Private Equity
Recent News
2022-10-14
2022-10-06
Company data provided by crunchbase